As Spanish hospital debt of €6.4bn breaks the 50% barrier, is Spain 'Greece' after all?
This article was originally published in Scrip
Executive Summary
Spain appears to be spiralling even further into debt with the pharmaceutical industry as it continues to delay payments to industry. It now owes pharma €6.4 billion, equivalent to 57.4% of the annual sales of drugs in Spain in 2011.
You may also be interested in...
Almirall launches Constella in six European markets
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira raises $35m in series B
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis ups public offering to $240m
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.